Carderock Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.44M Buy
40,090
+1,339
+3% +$287K 1.85% 24
2026
Q1
$8.57M Buy
38,751
+1,666
+4% +$408K 2.12% 19
2025
Q4
$9.4M Buy
37,085
+7,344
+25% +$1.84M 2.28% 16
2025
Q3
$7.36M Buy
29,741
+1,354
+5% +$324K 1.79% 30
2025
Q2
$6.82M Buy
28,387
+1,969
+7% +$458K 1.75% 33
2025
Q1
$5.99M Sell
26,418
-504
-2% -$111K 1.59% 36
2024
Q4
$5.53M Sell
26,922
-2,666
-9% -$585K 1.39% 41
2024
Q3
$7.18M Sell
29,588
-2,341
-7% -$547K 1.69% 34
2024
Q2
$7.01M Buy
31,929
+4,292
+16% +$932K 1.83% 32
2024
Q1
$6.21M Buy
27,637
+8,107
+42% +$1.83M 1.74% 34
2023
Q4
$4.29M Buy
+19,530
New +$4.13M 1.19% 43

Other funds holding STE

Carderock Capital Management's STE Position: Q2 2026 in Review

Carderock Capital Management increased its Steris (STE) stake by 3.5% in Q2 2026, buying an estimated $287K and bringing the position to 40,090 shares worth $8.44M. The position accounts for 1.85% of the portfolio, ranked #24.

Carderock Capital Management first reported a position in STE in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.4M in Q4 2025. 837 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Carderock Capital Management held 40,090 shares of Steris worth $8.44M as of Q2 2026.
  • Carderock Capital Management bought 1,339 Steris shares in Q2 2026, an estimated $287K.
  • Steris made up 1.85% of Carderock Capital Management's portfolio in Q2 2026, its #24 holding.
  • Carderock Capital Management first reported a position in Steris in Q4 2023 and has held it in 11 quarters since.
  • Carderock Capital Management's Steris position peaked at $9.4M in Q4 2025.
  • 837 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Carderock Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.